During this webinar, Dr. Mazzarelli’s presentation will review the unmet imaging needs in recurrent and metastatic breast cancer, estrogen receptor heterogeneity in metastatic breast cancer, and the acquisition and interpretation of Cerianna. He will also review cases that demonstrate how determining full-body ER + lesions status may impact patient care.
Cerianna™: Seeing Deeper into Recurrent or Metastatic Breast Cancer
